Novozymes A/S
XMUN:NZM2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Novozymes A/S (NZM2) under the Base Case is 6.95 EUR per share.
Compared with the current market price of 60.58 EUR, the stock appears
Overvalued by 89% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Novozymes A/S Does
Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly.
- Headquarters
- Denmark DK
- Employees
- 6 184
- IPO date
- May 27, 1905
Earnings Waterfall
Novozymes A/S
What is the Intrinsic Value of one NZM2 stock?
The intrinsic value for Novozymes A/S (NZM2) under the Base Case is 6.95 EUR.
Is NZM2 stock undervalued or overvalued?
Compared with the current market price of 60.58 EUR, the stock appears Overvalued by 89% .
